Skip to main content

Personalizing Treatment in High Grade Glioma
Using 3D Ex Vivo Technology

High Grade Glioma (HGG) Functional Precision Medicine—A Six Webinar Series

Virtual 60-minute webinar featuring expert discussion of real world HGG patient cases.

SESSION 3 of 6

For this third installment of a six webinar series, join us to hear how Dr. Rodriguez of the University of Arkansas is using live patient-specific tumor tissue to predict therapeutic response(s) in HGG patients before treatment initiation.

HGG patients have an extremely poor prognosis. Limited diagnostic tools are available to accurately predict treatment responses, leading to challenges in selecting effective therapeutic options. This interactive discussion features three real world clinical cases, presented by Dr. Analiz Rodriguez of the University of Arkansas, where a new functional precision oncology assay was used to direct therapy.

This Functional Precision Medicine Webinar Series is powered by OncoLens. On a single, secure platform, OncoLens data science, informatics and advanced collaboration tools provide a first of a kind platform for targeted treatment planning and confident clinical decision making.

Watch Session Cases Individually

Case #1 — 25 year-old male
Original diagnosis (2019): Li Fraumeni
Location: Left temporal region
Pathology: GBM
Progressions: 5 surgeries for recurrent disease, ommaya for intrathecal therapy

Case #2 — 25 year-old male with Grade 4 IDHm astrocytoma in 2020
Original diagnosis (2013): WHO grade 2 astrocytoma
3rd craniotomy in 2019: WHO grade 3 astrocytoma
4th craniotomy in 2020: WHO grade 4 astrocytoma

Case #3 — 59 year-old male with new onset seizure
Original diagnosis (2022): Presumed HSV Encephalitis
Location : Left temporal region
Central necrosis heterogeneous enhancement edema at 1 month

FEATURED SPEAKER:

Analiz Rodriguez, MD, PhD, FAANS

Director of Neurosurgical Oncology
Associate Professor and Vice Chair of Research
Department of Neurosurgery
University of Arkansas for Medical Sciences

High Grade Glioma (HGG) Functional Precision Medicine Webinar Series

MODERATORS:

Eric Perreault

Chief Business Officer
Kiyatec

Aubrey Ledford, PhD

Medical Affairs Director
Kiyatec

Other Sessions

Latest